|Bid||87.35 x 100|
|Ask||87.43 x 100|
|Day's Range||86.87 - 87.56|
|52 Week Range||80.69 - 104.71|
|PE Ratio (TTM)||37.06|
|Earnings Date||May 1, 2018 - May 7, 2018|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||99.00|
The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Over the last month, growth of ETFs holding MASI is favorable, with net inflows of $4.81 billion. This is among the highest net inflows seen over the last one-year and the rate of additional inflows appears to be increasing.
Masimo announced today the findings of a recently published study in which researchers at Cairo University in Egypt evaluated the accuracy and trending of Masimo non
Masimo today announced that its management is scheduled to present at the Barclays Global Healthcare Conference at the Loews Miami Beach Hotel on Tuesday, March 13, 2018 at 4:20 p.m.
Today at the 2018 HIMSS Annual Conference, Masimo announced the release of Replica™, an application for smart phones and tablets that works in conjunction with Masimo Patient SafetyNet™*, a supplemental remote monitoring and clinician notification system.
Masimo today announced that its management is scheduled to present at the 39th Annual Raymond James Institutional Investors Conference at the Marriott Grande Lakes in Orlando on Wednesday, March 7, 2018 at 8:05 a.m.
Masimo Corp (NASDAQ:MASI) files its latest 10-K with SEC for the fiscal year ended on December 31, 2017.
The maker of non-invasive monitoring technologies reported another great quarter, with record sales of its SET pulse oximeters.
The Irvine, California-based company said it had net income of 1 cent per share. Earnings, adjusted for pretax expenses and costs related to mergers and acquisitions, came to 72 cents per share. The results ...
NEW YORK, NY / ACCESSWIRE / February 27, 2018 / Masimo Corporation (NASDAQ: MASI ) will be discussing their earnings results in their Q4 Earnings Call to be held on February 27, 2018 at 4:30 PM Eastern ...
Masimo announced today that NU Hospitals, a leading nephrology care center in India, has standardized on Masimo technologies across the continuum of care. NU Hospitals have entered into a strategic partnership with Masimo to adopt technologies in their operating rooms , intensive care units , dialysis beds, and general wards at both of their facilities in Bangalore.
New study proves that Masimo's (MASI) noninvasive SpHb is more efficient in hemoglobin monitoring when compared to invasive LabHb.
Masimo announced today the findings of a recently published study in which researchers at Michigan State University evaluated the performance of noninvasive hemodyna
NEW YORK, Feb. 20, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of NewJersey ...
The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Index (PMI) data, output in the Healthcare sector is rising.
Masimo announced today the findings of a recently published study in which researchers at Bülent Ecevit University in Zonguldak, Turkey compared two noninvasive meth
Masimo announced today the CE marking of Eve™, a critical congenital heart disease newborn screening application, for the Rad-97™ Pulse CO-Oximeter®. Eve combines the power of Masimo SET® Measure-through Motion and Low Perfusion™ pulse oximetry with a pre-ductal to post-ductal synchronization algorithm designed to reduce calculation errors.